Clarity Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2018 - 2019
Other Revenue	10.78	11.51	9.8	6.46	3.2	2.79	Upgrade
Revenue	10.78	11.51	9.8	6.46	3.2	2.79	Upgrade
Revenue Growth (YoY)	13.61%	17.41%	51.74%	102.07%	14.62%	5.50%	Upgrade
Gross Profit	10.78	11.51	9.8	6.46	3.2	2.79	Upgrade
Selling, General & Admin	12.53	10.52	4.71	4.61	3.83	2.82	Upgrade
Research & Development	54.64	45.78	31.46	18.9	9.68	7.03	Upgrade
Operating Expenses	67.17	56.31	36.16	23.51	13.51	9.85	Upgrade
Operating Income	-56.39	-44.8	-26.36	-17.05	-10.31	-7.06	Upgrade
Interest Expense	-	-	-	-	-	-0.01	Upgrade
Interest & Investment Income	4.55	2.77	1.86	0.1	0.04	0.06	Upgrade
EBT Excluding Unusual Items	-48.47	-42.03	-24.5	-16.95	-10.27	-7	Upgrade
Other Unusual Items	-	-	-	-6.78	0.05	0.05	Upgrade
Pretax Income	-48.47	-42.03	-24.5	-23.74	-10.22	-6.95	Upgrade
Income Tax Expense	0.24	0.3	0.1	0.02	-	-	Upgrade
Net Income	-48.7	-42.32	-24.6	-23.75	-10.22	-6.95	Upgrade
Net Income to Common	-48.7	-42.32	-24.6	-23.75	-10.22	-6.95	Upgrade
Shares Outstanding (Basic)	301	273	260	248	176	146	Upgrade
Shares Outstanding (Diluted)	301	273	260	248	176	146	Upgrade
Shares Change (YoY)	15.21%	5.22%	4.81%	40.37%	20.54%	2.86%	Upgrade
EPS (Basic)	-0.16	-0.15	-0.09	-0.10	-0.06	-0.05	Upgrade
EPS (Diluted)	-0.16	-0.15	-0.10	-0.10	-0.06	-0.05	Upgrade
Free Cash Flow	-47.01	-43.74	-27.55	-13.53	-7.74	-6.84	Upgrade
Free Cash Flow Per Share	-0.16	-0.16	-0.11	-0.06	-0.04	-0.05	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-523.30%	-389.35%	-269.00%	-263.94%	-322.65%	-253.06%	Upgrade
Profit Margin	-451.93%	-367.82%	-251.03%	-367.78%	-319.77%	-249.35%	Upgrade
Free Cash Flow Margin	-436.21%	-380.14%	-281.07%	-209.43%	-242.06%	-245.44%	Upgrade
EBITDA	-56.21	-44.65	-26.26	-17	-10.3	-7.04	Upgrade
EBITDA Margin	-	-	-267.97%	-263.22%	-	-252.45%	Upgrade
D&A For EBITDA	0.19	0.15	0.1	0.05	0.02	0.02	Upgrade
EBIT	-56.39	-44.8	-26.36	-17.05	-10.31	-7.06	Upgrade
EBIT Margin	-	-	-269.00%	-263.94%	-	-253.06%	Upgrade
Revenue as Reported	18.7	14.28	11.66	6.55	3.29	2.9	Upgrade

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.